A detailed history of Spirepoint Private Client, LLC transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Spirepoint Private Client, LLC holds 10,711 shares of PPH stock, worth $936,569. This represents 0.13% of its overall portfolio holdings.

Number of Shares
10,711
Previous 11,480 6.7%
Holding current value
$936,569
Previous $1.05 Billion 3.08%
% of portfolio
0.13%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$90.59 - $99.43 $69,663 - $76,461
-769 Reduced 6.7%
10,711 $1.02 Billion
Q2 2024

Aug 08, 2024

BUY
$84.87 - $93.23 $43,623 - $47,920
514 Added 4.69%
11,480 $1.05 Billion
Q1 2024

May 10, 2024

BUY
$82.63 - $90.89 $906,120 - $996,699
10,966 New
10,966 $995 Million

Others Institutions Holding PPH

About VANECK ETF TR VANECK PHARMACEU


  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Spirepoint Private Client, LLC Portfolio

Follow Spirepoint Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spirepoint Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spirepoint Private Client, LLC with notifications on news.